Organogenesis Holdings is Biotechnology in United States that focus on Organogenesis Holdings Inc business. Founded in 1985. They cover business area such as Organogenesis Holdings Inc, manufacture, commercialization, product solution, surgical and sport medicine market, its product category, Advanced Wound Care, Surgical, Sports, Medicine, maximum revenue, PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft.
1985
( 39 years old in 2024 )
Organogenesis Holdings Inc
-
85 Dan Road
Canton, MA 02021
United States
Private
Organogenesis Holdings Incmanufacturecommercializationproduct solutionsurgical and sport medicine marketits product categoryAdvanced Wound CareSurgicalSportsMedicinemaximum revenuePuraPly AntimicrobialAffinityNuShieldApligrafDermagraft
* We use standard office opening hours in near Organogenesis Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Organogenesis Holdings is Biotechnology business from United States that founded in 1985 (39 years old in 2024), Organogenesis Holdings business is focusing on Organogenesis Holdings Inc.
Organogenesis Holdings headquarter office and corporate office address is located in 85 Dan Road Canton, MA 02021 United States.
Organogenesis Holdings was founded in United States.
In 2024, Organogenesis Holdings is currently focus on Organogenesis Holdings Inc sector.
Above is snippet of Google Trends for "Organogenesis Holdings Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Organogenesis Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
